Author
1. Gopal Lingam
2. Bhargava Mayuri
3. Xinyi Su
4. liu Zeng Ping
5. Lingam Swathi
ISBN
9789390595853
DOI
10.5005/jp/books/18562_14
Edition
1/e
Publishing Year
2022
Pages
25
Author Affiliations
1.
Medical Research Foundation, Sankara Nethralaya, Chennai, India,
Sankara Nethralaya, Chennai, Tamil Nadu, India,
University Health System, Singapore, Shri Mahavir Vitreoretinal Service, Medical Research Foundation, Sankara Nethralaya, Chennai, Tamil Nadu, India,
National University Hospital, Singapore, Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore Eye Research Institute SERI) Singapore
2.
National University Hospital, Singapore
3.
National University Hospital, Singapore, Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore Eye Research Institute (SERI) Singapore, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore
4.
Yong Loo Lin School of Medicine, National University of Singapore, Singapore Eye Research Institute (SERI) Singapore, Institute of Molecular and Cell, Biology (IMCB), Agency for Science, Technology and Research (A*STAR) Singapore
5.
Yong Loo Lin School of Medicine, National University of Singapore, Institute of Molecular and Cell, Biology (IMCB), Agency for Science, Technology and Research (A*STAR) Singapore
Chapter keywords
Retinal degenerative disorder,
gene therapy,
cell replacement therapy,
management,
retinitis pigmentosa,
age-related macular degeneration,
AMD,
polymorphism,
mutation,
gene therapy approach,
optogenetic therapy,
stem cell
